concept

TAU PHOSPHORYLATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TAU PHOSPHORYLATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

445Connections

1Hypotheses

10Analyses

50Outgoing

50Incoming

0Experiments

20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	TAU PHOSPHORYLATION
Key Genes/Proteins	APOE, BDNF, CDK5, GLUT4
Related Diseases	ACETYLCHOLINE, ALZHEIMER'S DISEASE, AUTOPHAGY, CERAMIDE, DEMENTIA

Pathway Diagram

graph TD
    TAU_PHOSPHORYLATION["TAU PHOSPHORYLATION"]
    TAU_PHOSPHORYLATION -.biomarker for.-> Down_syndrome["Down syndrome"]
    TAU_PHOSPHORYLATION -.biomarker for.-> Alzheimer_s_disease["Alzheimer's disease"]
    Glucocorticoid_Receptor["Glucocorticoid Receptor"] -->|"regulates"| TAU_PHOSPHORYLATION
    Amyloid__["Amyloid-beta"] -->|"activates"| TAU_PHOSPHORYLATION
    phytochemicals["phytochemicals"] -->|"regulates"| TAU_PHOSPHORYLATION
    p38_MAPK["p38 MAPK"] -->|"activates"| TAU_PHOSPHORYLATION
    A_["Abeta"] -->|"activates"| TAU_PHOSPHORYLATION
    NPTX2["NPTX2"] -->|"target for"| TAU_PHOSPHORYLATION
    WIF1["WIF1"] -->|"target for"| TAU_PHOSPHORYLATION
    AMYLOID["AMYLOID"] -->|"regulates"| TAU_PHOSPHORYLATION
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"expressed in"| TAU_PHOSPHORYLATION
    AMYLOID___PLAQUES["AMYLOID-Beta PLAQUES"] -->|"expressed in"| TAU_PHOSPHORYLATION

Outgoing (54)

Target	Relation	Type	Str
TAU	modulates	protein	0.95
Microtubule Instability	causes	phenotype	0.90
tauopathies	causes	disease	0.90
Alzheimer's Disease	contributes_to	disease	0.90
Alzheimer's Disease	associated_with	disease	0.90
Neurodegeneration	contributes_to	process	0.90
Neurodegeneration	contributes_to	process	0.85
Neurofibrillary Tangles	contributes_to	phenotype	0.85
Alzheimer's Disease	drives	disease	0.85
Neuronal Degeneration	causes	process	0.85
Tau Aggregation	associated_with	process	0.85
Alzheimer's Disease	biomarker_for	disease	0.80
Alzheimer's Disease Neuropathology	contributes_to	mechanism	0.80
Alzheimer'S Disease	contributes_to	disease	0.80
Redox Imbalance	causes	process	0.75
Alzheimer's disease	biomarker_for	disease	0.70
AUTOPHAGY	activates	phenotype	0.70
SNAP25	activates	gene	0.70
Alzheimer's disease	causes	disease	0.70
neurodegeneration	causes	phenotype	0.70
Down syndrome	biomarker_for	disease	0.70
WNT PATHWAY	regulates	pathway	0.65
AUTOPHAGY	phosphorylates	phenotype	0.65
NEURONS	interacts_with	cell_type	0.65
MAPK	inhibits	gene	0.65
ACETYLCHOLINE	regulates	phenotype	0.65
Infection	associated_with	disease	0.50
GSK3	regulates	concept	0.50
PREFRONTAL CORTEX	associated_with	brain_region	0.50
AMYGDALA	associated_with	brain_region	0.50
EMPAGLIFLOZIN	associated_with	drug	0.50
Neuron	associated_with	cell_type	0.50
Microglia	associated_with	cell_type	0.50
Proteins	activates	protein	0.50
ORGANOIDS	associated_with	concept	0.50
AMYLOID-β	regulates	concept	0.50
GLIOSIS	associated_with	concept	0.50
Nlrp3 Inflammasome	causes	pathway	0.50
Nlrp3 Inflammasome	activates	pathway	0.50
IPSC	expressed_in	concept	0.50
IPSC	inhibits	concept	0.50
INSULIN	activates	concept	0.50
LITHIUM	associated_with	drug	0.50
VISUAL CORTEX	associated_with	brain_region	0.50
AMYLOID-β	inhibits	concept	0.50
INSULIN SIGNALING	associated_with	pathway	0.50
WNT SIGNALING	associated_with	pathway	0.45
CORTEX	associated_with	brain_region	0.45
MEMANTINE	associated_with	drug	0.45
WNT PATHWAY	associated_with	pathway	0.45

Incoming (391)

Source	Relation	Type	Str
miR-219-5p	mediates	biomarker	0.95
R406	inhibits	drug	0.95
SYK	regulates	gene	0.95
Neddylation Inhibition	upregulates	mechanism	0.92
STING	activates	protein	0.92
ceramide	promotes	compound	0.90
AMPK	promotes	protein	0.90
24713000	mediates	paper	0.90
Ceramide	promotes	compound	0.90
24713000	is required for	paper	0.90
Lumacaftor	inhibits	drug	0.90
35887339	decreased	paper	0.90
41478829	competes with	paper	0.90
GSK3B	regulates	gene	0.90
IL-1β	causes	protein	0.90
STING	upregulates	protein	0.90
O-GlcNAcylation	inhibits	process	0.90
37865646	ameliorates	paper	0.90
LARS2	inhibits	gene	0.90
GSK3B	activates	gene	0.90
miR-219-5p	activates	biomarker	0.90
Testosterone	inhibits	compound	0.90
BAY 61-3606	inhibits	drug	0.90
37865646	mimics inhibitory effect of sTREM2 on	paper	0.90
CDK5/p25	causes	kinase	0.90
PKR	mediates	protein	0.88
TBK1	upstream_of	protein	0.88
Chronic Sleep Deprivation	causes	process	0.85
GMPR1	associated_with	protein	0.85
Lipopolysaccharide	associated_with	compound	0.85
LRRK2	associated_with	protein	0.85
TYROBP	regulates	protein	0.85
TTBK1	involved_in	enzyme	0.85
GSK-3β	involved_in	enzyme	0.85
MAPK14	mediates	protein	0.85
Brain Cholesterol Accumulation	promotes	phenotype	0.85
Amyloid-β	associated_with	compound	0.85
NLRP3 Inflammasome	mediates	pathway	0.85
GSK3B	mediates	protein	0.85
TBK1	mediates	protein	0.85
PP2A	downregulates	protein	0.85
Rg1	inhibits	compound	0.80
GSK3B	upregulates	protein	0.80
neurons	activates	cell_type	0.80
Hyperbaric Oxygen Therapy	inhibits	drug	0.80
BDNF	disrupts	gene	0.80
amyloid-beta	promotes	protein	0.80
NF-κB	modulates	protein	0.80
GMPR	modulates	gene	0.80
Oxidative Stress	upregulates	process	0.80

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Gamma entrainment suppresses hippocampal ERK1/2 hyperactivit	0.686	Alzheimer's disease	Gamma entrainment therapy to restore hip

Mentioning Analyses (10)

Scientific analyses that reference this entity

Does tau dendritic missorting persist independently after Aβ clearance, maintain

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.740

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

neurodegeneration | 2026-04-17 | 0 hypotheses

Variant Annotation and Prioritization of AD Risk Loci

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.862

What are the specific molecular determinants that govern tau strain selection du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.636

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

neurodegeneration | 2026-04-15 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (20)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

closed · Rounds: 4 · Score: 0.12 · 2026-04-27

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

closed · Rounds: 4 · Score: 0.42 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

closed · Rounds: 4 · Score: 0.47 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

closed · Rounds: 4 · Score: 0.52 · 2026-04-27

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

closed · Rounds: 4 · Score: 0.72 · 2026-04-27

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Related Research

Hypotheses and analyses mentioning TAU PHOSPHORYLATION in their description or question text

No additional research found

TAU PHOSPHORYLATION

Understanding Entity Pages

Pathway Diagram

Outgoing (54)

Incoming (391)

Targeting Hypotheses (1)

Mentioning Analyses (10)

Does tau dendritic missorting persist independently after Aβ clearance, maintain

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

Variant Annotation and Prioritization of AD Risk Loci

What are the specific molecular determinants that govern tau strain selection du

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

Extracellular vesicle biomarkers for early AD detection

Does DNAJB6 directly inhibit cross-seeding between tau, α-synuclein, and TDP-43

Senescent cell clearance as neurodegeneration therapy

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

Tau propagation mechanisms and therapeutic interception points

Experiments (0)

Related Papers (0)

Debates (20)

Extended debate: Metabolic Reprogramming to Reverse Senescence

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Related Research